Quest Diagnostics – VP/General Manager, Infectious Disease & Immunology
Responsible for managing the growth of Quest’s IDI business, focusing on creating value for customers through market creation, expansion, and overall portfolio lifecycle management, Ruth has also been instrumental in Quest’s response planning for Covid-19. She joined Quest in 2019 from Novartis, where she had most recently served as Commercial Lead – New Product Marketing Respiratory & Dermatology, responsible for the development of disease area strategies and the evaluation of business development opportunities. Prior to that position, Ruth held other strategic roles at Novartis such as Executive Director – Head of Marketing Neuroscience; and VP Marketing and Sales & Business Unit Head -Neuroscience. She has also held several key management positions during her career at Acorda Therapeutics, Bayer, Organon and Allergan. Ruth holds a master’s degree in pharmacy from the University of Utrecht (The Netherlands).